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ABSTRACT 
Acharya Kashyapa in Revatikalpa adhyaya explained about the Jataharinies, as a group of demons 
who has divine vision, attack women to destroy or to produce serious problems of menstrual cycle, 
recurrent abortions, still birth, intrauterine fetal death, neonatal deaths or severe disorders which 
decreases the life span of the fetus. As recurrent miscarriage, intrauterine death of an infant or 
death at birth has always been a devastating experience for the mother and of concern in clinical 
practice. All these mortality remains a challenge in the care of pregnant women worldwide, 
particularly for those who had history of adverse outcome in previous pregnancies (BOH). 
Antiphospholipid antibody syndrome (Hughes syndrome) is an autoimmune, hypercoagulable state 
caused by antiphospholipid antibodies. Pregnancy related complications are miscarriage, still 
birth, preterm delivery, IUD etc. This is one of the few treatable causes of pregnancy loss, and 
successful pregnancy rates of 70% or more can be achieved with appropriate treatment. 
Description of Jataharinies resemble with APLA, hence critical analysis will help to emphasize on 
management of Jataharinies by Ayurvedic treatment principles. 
KEYWORDS: Jataharinies, Anti-phospholipid antibody syndrome, BOH. 
INTRODUCTION 
 Pregnancy is unique, exciting and joyous time 
in woman’s life as it highlights woman’s amazing 
creative power. Many of auto immune diseases have 
predisposition for woman in their child bearing 
age[1]. With the exception of pregnancy with 
rheumatoid arthritis auto immune diseases are 
associated with increased risk of adverse pregnancy 
outcome. Antiphospholipid antibody syndrome 
(APLA Syndrome) is an autoimmune, hyper 
coagulable state caused by Antiphospholipid 
antibodies. Pregnancy related complications are such 
as miscarriage, stillbirth, Intra I.U.D (Intra uterine 
death) etc. It is one of the few treatable causes of 
pregnancy loss and successful pregnancy rates of 
70% or more can be achieved with appropriate 
treatment. 
In our classics Kasyapa Samhita, 
Kalpasthanam, chapter-6 “Revatikalpadhyaya” it has 
been mentioned that due to misdeeds of pregnant 
mother and father, “Jataharinies” kill the mother and 
fetus[2]. She causes loss of progeny, loss of longevity 
of children due to one’s own misdeeds. The 
Jataharinies, means a group of demons who have 
divine vision, attack women to destroy or to produce 
serious problems of menstrual cycle, recurrent 
abortions, still birth, intra uterine fetal death, 
neonatal deaths or severe disorders which decreases 
the life span of the fetus. 
Incidence[3]- It is 15-17% in European and American 
whites. 1-2% in India. The incidence of Rh- negativity 
at Safdarjung hospital is 7%. 15 percent of more than 
1000 women with recurrent pregnancy loss had 
recognized autoimmune factors. [Kutteh and 
Pasquarette (1995)]. The incidence of APLA in 
general obstetrical population is about 5%. 
Review of Jataharini 
Causes and effect of Jataharinies Affliction 
According to Kasyapa Samhita causes of Jataharini 
attack can be summarized as[4,5,6,7] 
 Adharma 
 Mithyahara-Vihara or Dosha Prakopaka 
nidanas either male or female partners 
 Susceptible stages are menstruating woman, 
pregnant woman, puerperal woman and the 
lady who lives in Hut. 
These women are likely to get afflicted by 
Jataharini which can be observed by- 
1. Destruction of Menstruation 
2. Destruction of Fetus  
3. Stillbirth 
4. I.U.D 
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Types of Jataharinies[8]- On the basis of prognosis 
these are of three types 
A) Sadhya (curable)  
B) Yapya (easily relapsable) 
C) Asadhya (Incurable) 
A) Sadhya Jataharinies- 11 in number 
1. Shushka revati 
2. Katmabhara 



































Types of Jataharinies (on the basis of mode of 
transmission) according to another classification[9] 
3 types 
a) Daivi (devine) 
Acharya Kashyapa after getting knowledge of Revati 
by his intense penance (Tapa) and described it to his 
disciples for the sake of universe. 
b) Manushi (human)- It is sub-classified into four  
1. Varna 
2. Varnantara  
3. Lingini 
4. Karuki  
c) Tirashchin (animals)- It is sub-classified into 
five 
1. Shakuni (Birds)    
2. Vanaspati (plants)    
3. Chatushpadi (four legged animals)  
4. Matsi (fishes) 
5. Sarpa (Reptiles) 
Sadhya Jataharinies– In alive mothers these are 10 or 11 in number 
No. Name of 
Jataharinies 
Properties mentioned by Kashyapa Inference 
1 Shushka revati Girls not getting menarche at the age of 16 or 
lady who is emaciated having delayed menses  
Delayed menarche or 
amenorrhoea due to nutritional or 
hormonal cases 
2 Katambhara The woman who is emaciated, weak, and 
irritable, dies in her mature age without having 
menstruation 
Primary amenorrhoea 
3 Pushpaghni Although woman gets her menstruation at time 
but she has anovular menstruation so she is 
unable to conceive and suffers from obesity, 
fatty cheeks with hairs 
Polycystic ovarian syndrome or 
excessive androgen levels 
4 Vikuta Woman gets menstruation but suffering from 
irregularity in duration, colour, amount and 
feels exhausted without any cause 
Irregular menstrual and Ovulatory 
cycle. 
5 Parisruta Emaciated woman having constant and 
excessive discharge per vaginum 
Excessive leucorrhoea or 
discharges due to infections 
6 Andaghni Causes repeated early abortions at blastocyst 
stage 
Early abortions at Blastocyst stage 
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7 Durdhara Causes repeated abortions after formation of 
Garbhanga and harms life of woman 
First and second trimester 
abortions 
8 Kalaratri Destroys the fetus possessing complete body 
suddenly, along with threat to the life of mother. 
Sudden fetal death 
9 Mohini Causes non attachment of embryo or its 
expulsion after attachment along with death of 
woman. 
Rupture of ectopic pregnancy or  
10 Stambhani Fetus does not quiver Intra uterine demise 
11 Kroshana Fetus situated in uterus creates various 
complications 
Irritable uterus i.e. threatened 
abortion 
 Yapya Jataharinies- These are sixteen in number. In woman doing righteous acts these are relapsable. 
No. Name of Jataharini Properties Mentioned by Kashyapa Inference 
1  Nakini Always delivers dead fetus. Repeated still births 
2  Pishachi Fetus dies immediately after birth Early neonatal death 






 Neonatal death from  


























Asadhya Jataharinies: These are eight in number 
No. Name of Jataharini Properties mentioned by Kashyapa Inference 
1 Vashya Repeated intra-uterine death of fetuses in 5th, 6th or 7th 
month. 
Intra uterine death 
2 Kulakshayakari Woman whose sons die and daughters survive even 
without proper care 
- 
3 Punyajani Children of the afflicted woman die immediately after 
birth. 
- 
4 Paurushadini Progeny die before attaining the age of sixteen years Some hemolytic 
disorders 
5 Sandamshi Immediately after conception the child born just 
before this conception dies. 
- 
6 Karkotaki When conceives her one child(of twins) dies and 
another suffers from Balagraha 
Twin pregnancy 
complications 
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8 Badawamukhi When one child of one Nabhija (uniovular) twin dies 
first and subsequently second also dies. 
Twin pregnancy 
complications 
Clinical features[10] after affliction of Jataharinies  
Due to affliction of Jataharini the woman gets 
withered and has these clinical features: 
1. Drishtivyakulataa: Woman suffers from 
bewildered looks. 
2. Yathaakaalam na pushyati: She suffers from 
absence of nourishment in appropriate time. 
3. Bhrashtasatva: She suffers from unsteadiness of 
Psychology (Satva). 
4. Nirutsaahaa: She suffers from absence of 
enthusiasm. 
5. Kukshishoola: She suffers from pain in abdomen. 
6. Bhavatya Apriyaroopa: She suffers from 
disagreeable looks. 
7. Roghah upadruta: She suffers from various 
disorders. 
8. Vipareetasamaarambha: She commences every 
work in opposite way. 
9. Vipareetanishevanee: She consumes opposite or 
non-congenial edibles.   
10. Vaidhavya: She becomes widow. 
11. Ayashah: She faces failure at every work and loss 
of wealth. 
12. Kulakshayakari: Jataharini after seizing 
destructs her family. 
Chikitsa[11] of Jataharinies 
1. Avasinchan of afflicted woman by the woman 
from whom she got Jataharini  
2. Prajavaran Bandha 
3. Putrakameshti Yajna 
Brief Review of Antiphospholipid Antibody 
(APLA) Syndrome 
 Antiphospholipid syndrome or antiphospholipid 
antibody syndrome (APS or APLS or Huges) is an 
autoimmune, hypercoagulable state caused by 
antibodies against cell-membrane phospholipids 
that provokes blood clots (thrombosis) in both 
arteries and veins as well as pregnancy-related 
complications such as miscarriage, stillbirth, 
preterm delivery, or severe pre-eclampsia.  
 The syndrome occurs due to the Autoimmune 
production of Antibodies against Phospholipid 
(APL) of the cell membranes. 
 Patients have laboratory evidence for Antibodies 
(IgG, IgM or IgA) against Phospholipids or 
Phospholipid- binding protein cofactors in their 
blood. 
Types of APLA Syndrome- Four types- 
1. Primary Antiphospholipid Syndrome (PAPS):  
When APS occurs in the absence of any other related 
disease (LA, ACL antibodies in patient’s serum). 
2. Secondary Antiphospholipid syndrome: 
When APS coexists with other diseases such as SLE I. 
3. In Catastrophic APLA (rare): 
APS leads to rapid organ failure due to generalized 
thrombosis and a high risk of death. 
4. Other: 
Rare antibodies to Phosphotidyl Ethanolamine and 
Phosphotidylserine are also associated with it. 
Which is not an APLA antibody? 
A) Anti Ro 
B) Anti Insulin Antibodies 
Which are the Antibodies? 
A) Lupus Anticoagulant (LAC) 
B) Anticardiolipin Antibodies (ACL) 
C) Anti Beta- 2 glycoprotein antibodies  
D) Other antibodies 
[A] Lupus anticoagulant (LAC) 
 LAC is characterized by a prolonged partial 
Thromboplastin time and paradoxically the so-
called ‘anticoagulant’ is a powerful thrombotic 
agent in vivo. 
 Higher thrombotic potential than ACL when 
present alone.  
 LAC interferes with platelet function, causing 
aggregation & thrombosis and also interferes 
with endothelial function, causing procoagulant 
activation & thrombosis.  
 Prevalence of LAC in 
 Low risk population is < 1% 
 Bad obstetric history - 9.1%, 
 Early pre eclampsia - 16%,  
 Abruption - 33%, 
 Systemic lupus erythematosus - 34%. 
[B] Anticardiolipin Antibodies (ACL) 
• ACL were thought to react against Cardiolipin but 
it is now thought to interact with B2GP1 
• 85% of APS patients have both LA & ACL 
• These can be detected using an ELISA.  
• Screens for the presence of β-2 Glycoprotein 1 
dependent Anticardiolipin antibodies (ACA) 
[C] Anti Beta- 2 GP1 
• Discovered after LA & ACL. 
• Found without other two in 11% of APS patients 
and commonly with others. 
• Binds to B2GP1 disrupting f(x). 
• B2GP1 has anticoagulant activity through the 
inhibition of the conversion of Prothrombin 
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Thrombin, regulation of protein S, & /or 
activation of platelets.  
Thrombophilic defects- Either Acquired or 
Inherited 
Thrombophilia- Tendency to thrombosis. 
[1] Acquired APLA 
1. Lupus anticoagulant antibodies 
2. Anticardiolipin antibodies 
 Myeloproliferative diseases 
 Malignancy 
 Paroxysmal nocturnal Haemoglobinuria 
 Nephrotic syndrome 
[2] Inherited APLA 
 Hyperhomocysteinemia (C677T) mutation 
 Factor V Leiden mutation (A506G) mutation  
 Mutation in Prothrombin ( G 20210 A)  
 Prothrombin II (PTII) mutation 
 Protein S deficiency 
 Protein C deficiency 
All these conditions should be investigated for 
APLA except 
 A.) Early onset severe Pre- Eclampsia  
 B.) Arterial or venous thrombosis  
 C.) Unexplained fetal growth restriction 
 D.) Gestational Diabetes  
Diagnosis of Apla 
• Due to fluctuating titers of the antibodies,  
• Lack of agreement between laboratories 
concerning standardization of the  assays, 
• Debates among researchers and clinicians 
concerning which antibodies to  measure. 
Pathology 
Pregnancy losses classified as: 
 Occult (preclinical or chemical) pregnancy loss 
prior to missed menses. (40% of implantation 
embryos) 
  Early pregnancy loss before 12 week (13%) 
  Late pregnancy loss after 12 week (1%) 
Causes of pregnancy loss: 
 Chromosomal- 55% of occult & early losses 5% 
of recurrent losses. 
 Environmental-  
1. Immunological- It includes 5% of early losses 
and 95% of late losses. 
2. Anatomical 
3. Hormonal 
What is Recurrent pregnancy loss? What actually 
causes it? 
• A Recurrent pregnancy loss (RPL) is three or 
more consecutive, spontaneous pregnancy losses, 
under 20 weeks of gestation from the last 
menstrual period by the same partner.  
• “Primary recurrent pregnancy loss” refers to 
couples that have never had a live birth.  
• “Secondary RPL" refers to those who have had 
repetitive losses following a  successful 
pregnancy. 
Primary Antiphospholipid Antibody Syndrome 
Presentation may be totally asymptomatic or in a 
classical manner 
Various clinical presentations, 
• Recurrent pregnancy loss  
• Unexplained second / third trimester loss  
• Early onset severe pre-eclampsia  
• Arterial or venous thrombosis  
• Unexplained fetal growth restriction  
• Prolonged coagulation studies  
• Autoimmune diseases  
• Cardiac valvular diseases  
• Neurological disorders  
• Thrombocytopenia 
Sapporo Criteria (updated) 
Pregnancy Criteria 
 One or more unexplained fetal deaths > 10 weeks 
of pregnancy.  
 One or more Pre-eclampsia/Eclampsia or 
placental insufficiencies occurring before 34 
weeks. 
 Three or more unexplained consecutive 
spontaneous abortions < 10 weeks. 
Laboratory criteria 
 LAC defined by a functional, clot-based assay 
(ISTH guidelines) 
 ACL (IgG or IgM) antibody 
 Anti-Beta-2 Glycoprotein 1, IgG or IgM antibody 
(Miyakis, et al., J. Thromb. Haemost., 2006; 4: 
295-306). 
Management 
Controversies surrounding treatment for 
pregnancy loss 
Evidence-based medicine (EBM) has not 
succeeded in giving patients and physicians, the data 
they need to choose (or not choose) a therapy in the 
field of pregnancy loss.  
How to proceed? 
• Interview the couple together 
• History of the case is very important 
• Clinical examination 
• Investigations as per the history  
• Reassurance and Counseling 
Int. J. Ayur. Pharma Research, 2020;8(Suppl 2):95-102 
     Available online at: http://ijapr.in  100 
• Treatment plan: Drugs, maternal and fetal 
surveillance, dealing with complications. 
• Timely referral to a tertiary centre. 
So how does one manage the drug treatment in 
pregnancy? 
General guidelines for anticoagulation in Pregnancy 
with APS leading to recurrent pregnancy loss is very 
controversial issue. 
Commonly used Drugs 
• Steroids: Reduces ACA, normalizes prolongation 
of invitro coagulation.  
Complications? 
Perinatal outcome, preterm labour, pre-
eclampsia. 
• Low dose Aspirin (LDA): Selective inhibition of 
Thromboxane A2 and no effect on PGI2. 
• Azathioprine  
• Warfarin 
Which is the commonly used drug for APLA? 
A) Progesterone 
B) Folic acid 
C) Low dose Aspirin 
D) RU- 486 
Unfractionated Heparin (UFH) 
• Potentiates complex formation with AT III + factor 
VII A  XII A & Thrombin 
• Complications: Reduces platelet bleeding and 
B.M.D. 
Low molecular weight Heparin (LMWH) 
 Once daily dose, less monitoring  
 Lesser Osteopenia, does not cross placenta 
 Cost factor. 
Trials 
 Heparin vs Aspirin + prednisolone  
Live birth 75% 
Pre-eclampsia, preterm delivery more in latter 
group. 
 L.S. + LDA Vs Heparin + LDA (n=20) 
 No placebo  
 Large multicentric trials needed (Cowchock et al 
.1994) 
DISCUSSION   
Pregnancy loss in the APLA syndrome 
 Both Jaataharini and APLA syndrome are 
silent killers of fetus inutero. The presence of APL 
antibodies will be detected usually when recurrent 
pregnancy loss occurs, which indicate that this is not 
a routine investigation in ANC. This will be the 
drawback for good fetal outcome. It is not precisely 
known how these antibodies cause damage, but it is 
likely that their actions are multifactorial. Ayurveda 
explains that for formation of Garbha, 
Panchamahabhuta and Beeja plays an important role. 
Both will be strongly influenced by Beeja dosha and 
Daiva. APLA starts with the pathology at the level of 
cell immunology and mainly genetic mutations, so 
Ayurveda explained some references related with 
fundamental factors. 
Role of Panchamahabhuta in Formation of 
APLA[12,13,14]  
There is no direct reference related to the 
Pathophysiology of Jataharinies, so by  considering 
the basic fundamentals we can postulate Samprapti 
like this 
 Panchamahabhutas, the basic entities in our body 
are responsible for establishment of structural and 
functional aspects. 
 Sushruta says “Apratihanana” i.e., continuation of 
normal functions is the property of 
Panchamahabhutas like Kayakriya, Vakkriya, also 
Garbhakriya. 
 Dhamanies carry these Mahabhutas in whole body 
and Dalhana clarifies that when the time of 
destruction comes first these Dhamanies will play 
a key role. 
Role of Rakta Dushti in formation of APLA[15,16,17] 
According to Sushruta Samhita we can observe that 
Rakta and Artava are having similar properties. 
Sushruta states that “Rakta Lakshanamartavam 
Garbhakrichcha”. Dalhana commenting on this says 
that Cha means all the functions of Rakta are also 
carried by Shuddha artava.  
• The effects of large amounts of estrogen, 
progesterone, and prolactin must be considered. 
For example, Estrogens up-regulate and 
Androgens down-regulate T-cell response, and a 
number of cytokines are regulated by sex 
hormones. (Lockshin and Druzin, 1995; Refojo 
and colleagues, 2003) 
• Lockshin (2002) postulates a modulating effect of 
hormones rather than a causative role. 
Role of Kapha Dosha[18] in Formation of APLA 
(According to Su.S. Shareera)  7/17-18):  
 In the pathology of APLA we have seen the 
role of Thrombogenesis which we can observe in 
Sushruta’s opinion. Bahala i.e., clotting and 
Gairikodaka Prateekansham which is nothing but 
normal consistency of Rakta are brought by normal 
Kapha. In pregnancy normal physiological 
hematological changes like increased plasma volume 
may lead to production of thrombotic agents and 
antibodies. 
Kapha Bahala (clotting) and Gairikodaka 
prateekansham (the more plasma, which leads to the 
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production of Annexin V and antibodies). Mamsa, 
Peshee,  Prabham means clotting. (Su.S. Sutra.14/21) 
B-2 Glycoprotein 1 and Kapha dosha 
 B-2 Glycoprotein1 (Apolipoprotein H) Kapha 
being same property. 
Proteins are anabolic agents.  
 B-2 Glycoprotein 1 more on the surface of the 
syncytiotrophoblast. 
 B-2 Glycoprotein 1 inhibits clotting factors 
(Factor XII) and prothrombinase complex.  
• B-2 Glycoprotein may be involved in 
implantation because it is known that, this 
protein binds Heparin. Moreover, trophoblastic 
cells have Heparin like binding sites. 
• So, Kapha dushti cause accumulation of clotting 
factors in Rakta dhatu by allowing the Factor 
XII, Prothrombinase and preventing from 
binding with Heparin.  
• So fall in B-2 glycoprotein might prevent 
implantation or result in intervilleous space 
thrombosis or both. 
Role of Ojas[19,20] (Immunity) in Formation of 
APLA 
 Immunity in the aspect of Ayurveda is considered 
under Ojas. Sushruta states that if Ojas is absent, 
body tissues start to degenerate. Charaka clearly 
says that in Garbhavastha the Ojas is present in 
three forms 
1. Before the formation of Garbha ie, Saara of 
Shukra and Shonita act as Ojas. 
2. After formation of Kalala i.e., embryo in the form 
of Rasa Saara. 
3. During the organogenesis in the form of 
preventive cell layer or tissue layer.  
 The immune system is designed to protect cells, 
tissues, and organs perceived as self and to attack 
and destroy foreign or none self antigenic 
material by the production of antibodies. This 
protection has two phases:  
 Innate phase, which is broad and rapid and is 
mediated through Neutrophils, Macrophages, 
and complement.  
 Adaptive phase, which is precise and is caused 
by antigen-specific reactions through T and B 
lymphocytes that result in memory for future 
exposures (Parkin and Cohen, 2001). 
 The immune system may be stimulated to begin 
producing antibodies directed against self or 
normal tissues. These misdirected antibodies are 
called Auto-antibodies. The stimulus responsible 
for their production is unknown, but a variety of 
inciting reasons are suspected that include 
bacterial or viral injury to genetically susceptible 
tissues. Aggravated Vata dosha guides this 
phenomena with its property. As explained by 
Charaka acharya in (Cha. Su. 12/8) like, 
Vaayustantrayantradharah…..Kartaagarbhakriteena||  
 Auto-antibodies induce destruction in susceptible 
tissues by at least two mechanisms:  
 The cytotoxic mechanism involves direct 
antibody attachment to a  specific surface 
antigen, which results in cell injury or 
destruction. 
 The immune-complex mechanism results in 
tissue damage when the antigen–antibody 
complex attaches to a susceptible tissue. 
Samanya Chikitsa Sutra 
1) Garbhini Paricharya 
2)  Hygiene 
3) Timely treatment for minor ailments. 
4) Psychological support 
5) Pumsavana 
6)  Kledahara oushadhi prayoga especially in 2nd 
trimester 
7) Daiva vyapashraya chikitsa 
CONCLUSION 
Both Jaataharini and APLA syndrome are 
silent killers of fetus in utero. The presence of APL 
Antibodies will be detected usually when recurrent 
pregnancy loss occurs, which indicate that this is not 
a routine investigation in ANC. This will be the 
drawback for good fetal outcome. It is too difficult to 
draw accurate correlations and aetio-pathogenesis of 
Jaathaharini because of unavailability of full version 
of Kashyapa Samhita and no references in 
Brihatrayees. Only on the basis of unexplainable 
mode of onset of syndrome and fetal recurrent losses 
explained under this context, I tried to correlate these 
explanations under APLA syndrome. In cases of 
adverse pregnancy outcomes APLA should be kept in 
mind. The only intervention to have demonstrated 
benefit is serial ultrasound scans in early months of 
pregnancy. For patients with APLA/ Thrombophilia, 
referral to a tertiary unit as multidisciplinary 
management is required. Psychological support is 
required. Couple should be counselled together. 
Education and reassurance has an important role to 
play. 
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